Author: wjyk09 Submitted Date: 2009-8-9 16:45:00 Visit: 8 Reply: 0
Today's Liuzhou (Reporter Chen Xiaoyan) reporter yesterday from Liuzhou City, the Food and Drug Administration was informed that, after days of investigation, the city has not found the District Food and Drug Administration required immediate suspension of the sale and use of the "One-time use of blood perfusion device".It is understood that, according to the autonomous region of adverse drug reaction monitoring center report, as of July 17, Guangxi has three hospitals in the use of product labeled as Langfang Ai Er blood purification equipment factory production of "one-time use of blood perfusion device" (involving batch No. 20090430, 20090417, 20090601, 20090325) in the process of *** appeared 11 cases of adverse events, including 8 cases of anaphylaxis, itching 1 case, chest tightness and local numbness 2 cases.
In order to protect the public with the safety of the device, to prevent the further expansion of the adverse events, the autonomous region Food and Drug Administration decided to suspend the sale and use of single-use blood irrigators labeled as the above manufacturers and batch numbers throughout the region.
Liuzhou City Food and Drug Administration received the notice on the 18th, to the city's medical institutions and medical equipment business units issued an emergency inventory notice. As of 6 p.m. yesterday, according to the feedback from some units, Liuzhou City has not found the above products for the time being. At present, the inventory is still in progress.
Cited from:/gstg-20090718-1.htmThe newspaper Liuzhou (Reporter Chen Xiaoyan) reporter yesterday from the Liuzhou City Food and Drug Administration was informed that, after days of investigation, the city has not found the District Food and Drug Administration required immediate suspension of the sale and use of "one-time use of blood perfusion device".